Abstract |
Four-factor prothrombin complex concentrate is approved for use of life-threatening bleeding secondary to vitamin K antagonism in adults. We describe the use of four-factor prothrombin complex concentrate for hemostasis in a 6-week-old child with life-threatening vitamin K dependent- bleeding who never received vitamin K prophylaxis at birth.
|
Authors | Megan A Rech, Lindsay Wittekindt, Samantha D Friedman, Kendall Kling, David Ubogy |
Journal | The Journal of pediatrics
(J Pediatr)
Vol. 167
Issue 6
Pg. 1443-4
(Dec 2015)
ISSN: 1097-6833 [Electronic] United States |
PMID | 26454577
(Publication Type: Case Reports, Journal Article)
|
Copyright | Copyright © 2015 Elsevier Inc. All rights reserved. |
Chemical References |
- Blood Coagulation Factors
- prothrombin complex concentrates
|
Topics |
- Blood Coagulation
(drug effects)
- Blood Coagulation Factors
(administration & dosage)
- Cerebral Hemorrhage
(diagnosis, drug therapy, etiology)
- Female
- Humans
- Infant, Newborn
- Injections, Intravenous
- Vitamin K Deficiency Bleeding
(blood, complications, drug therapy)
|